71. Idiopathic osteonecrosis of the femoral head
3 clinical trials,   5 drugs   (DrugBank: 4 drugs),   4 drug target genes,   10 drug target pathways

Searched query = "Idiopathic osteonecrosis of the femoral head", "Idiopathic femoral head necrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03112785
(ClinicalTrials.gov)
March 17, 20117/3/2017Fitmore Versus CLS Stem in Total Hip Arthroplasty. Bilateral One-stage OperationsRandomized Comparison Between the Fitmore and the CLS Stem in Patients Operated in One-stage Due to Bilateral Symptomatous Hip DiseasePrimary Hip Osteoarthritis;Secondary Hip Osteoarthritis Due to Idiopathic Femoral Head Necrosis, Childhood or Inflammatory Disease;Bilateral Hip Disease;Surgical TreatmentDevice: Total hip arthroplasty (Fitmore or CLS uncemented femoral stem made by Zimmer-Biomet, Warshaw, USA)Sahlgrenska University Hospital, SwedenZimmer BiometActive, not recruiting35 Years75 YearsAll44N/ANULL